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ABSTRACT
Acute lymphoblastic leukemia (ALL) constitutes approxi-
mately 25% of the pediatric cancers. In general, the task of
identifying immature leukemic blasts from normal cells un-
der the microscope is challenging because morphologically
the images of the two cells appear similar. In this paper, we
propose a deep learning framework for classifying immature
leukemic blasts and normal cells. The proposed model com-
bines the Discrete Cosine Transform (DCT) domain features
extracted via CNN with the Optical Density (OD) space fea-
tures to build a robust classifier. Elaborate experiments have
been conducted to validate the proposed LeukoNet classifier.
1. INTRODUCTION
Cancer is a deadly disease and is responsible for millions
of deaths across the globe every year. Acute Lymphoblastic
Leukemia (ALL) constitutes approximately 25% of the pedi-
atric cancers [1]. Timely diagnosis with appropriate treatment
can help with increasing the overall survival of the cancer pa-
tients. However, high costs of the diagnostic tests pose chal-
lenges in providing access to the under-privileged population,
particularly, in rural areas.
In the recent past, convolutional neural networks (CNNs)
have achieved immense success in various domains such as
speech processing, computer vision, natural language pro-
cessing, etc. Since CNN architectures have translational in-
variance and an ability to learn both fine and coarse level fea-
tures, these architectures are well-suited for such tasks. For
example, CNNs have been employed in medical imaging for
various tasks such as segmentation [2], classification [3] , and
object detection [4].
Since the existing diagnostics tests based on flow cytom-
etry for the identification/counting of cancer versus normal
blasts in cancer are expensive, an automated machine learning
based classifier would be cost effective and easily deploy-able
in urban as well as rural areas. The problem is challenging
because 1) the cells are not distinguishable under the micro-
scope, 2) the subject level variability may render the classifier
ineffective on prospective subjects’ data, and 3) the classifica-
tion accuracy is desired on both the classes equally. Incorrect
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diagnosis of either true positive or true negative may prove fa-
tal for a subject, if the chemotherapy is not administered when
required or if a subject is administered extra chemotherapy
sessions when he/she cannot handle.
Deep learning based methods can help address all the
three above challenges because they extract desirable features
from the raw data itself and the architectures are generally
scalable. In this paper, we propose a novel CNN architecture
to classify immature leukemic blasts versus hematogones
(normal cells) that would be helpful in the treatment of B-
ALL (B-lineage acute lymphoblastic leukemia), a type of
white blood cell (WBC) cancer. For the sake of simplicity,
we name the immature leukemic blasts as cancer WBCs and
hemotagones as normal WBCs throughout the rest of the
paper. We use the Stain Deconvolution Layer (SD Layer) as
proposed by Duggal et al. [3] and extend the work with the
below contributions:
1. We add a Discrete Cosine Transform (DCT) layer on
the quantity images in the OD space, obtained after
the SD-layer. Since flow cytometry detects cells us-
ing spectrometry, we believe that there may be useful
features in the frequency domain that can be captured
by DCT layer-appended CNN architecture.
2. Further, we use a hybrid framework by combining
both DCT layer-appended CNN architecture and with-
out DCT layer-appended CNN architecture, ensuring
both frequency domain and spatial domain features are
captured appropriately.
3. We use bilinear pooling instead of average pooling after
the last conv layer because it is found to be helpful for
fine-grained visual recognition tasks [4].
2. RELATEDWORK
A lot of research work is done on microscopic image seg-
mentation, detection and classification. Particularly, for the
detection of cancer, extensive research has been carried out.
Xu et al. [5] used stacked sparse autoencoders for detection
of nuclei in breast cancer histopathology images. Zhang et
al. [6] proposed a deep convolutional network for directly
classifying cervical cells into normal and abnormal cells and
directly classified cells without segmenting them. Cruz-Roa
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et al. [4] proposed a deep learning architecture through which
the technique exploited the features in the intermediate layers
as digital staining and used it on on basal-cell carcinoma de-
tection whereas Wieslander et al. [7] proposed to detect the
changes due to malignancy by using Deep Neural Networks.
In the past, Singhal et al. [8] and Zhao et al. [9] proposed
machine learning algorithms using hand crafted features for
Acute Lymphoblastic Leukemia (ALL). Recently, Stain De-
convolution Layer (SD Layer) was proposed in for the clas-
sification of cancer versus normal cells. Rather than training
in RGB space, classifier was trained on the images in the Op-
tical Density (OD) space. This work in [3] is closest to our
work because the classifier is designed on the same dataset.
However, there are some fundamental differences. While the
classifier was built in [3] by mixing cell image data of all sub-
jects, we have separated the cell images at the subject level
and the classifier is trained on some subjects and tested on
other subjects. This ensures that no cell of a subject in the test
data has been shown to the classifier during training. In this
manner, we have attempted to learn the subject level variabil-
ity to ensure reasonably consistent results on the prospective
unseen subjects’ data. In addition, while a dataset of approx-
imately 9000 cell images was used in [3], we have used a
dataset of approximately 14000 cell images.
Fig. 1: Leukonet Architecture
3. DATASET DESCRIPTION
Microscopic images were captured from bone marrow aspi-
rate slides of patients diagnosed with B-ALL. Images were
captured in raw BMP format with a size of 2560x1920 pix-
els. Normal data has been collected from subjects who did
not suffer with cancer and hence, the ground truth labels are
100% correct for this class. Cancer cells have been segmented
from the microscopic images collected from the patients who
were initially diagnosed with cancer.
We prepared a dataset of 9211 cancer cells from 65 sub-
jects and 4528 normal cells from 52 subjects. These images
were normalized, the cells of interest were marked with labels
by the expert oncologist and segmented. A waiver for written
informed consent was obtained from the Ethics Committee of
AIIMS, New Delhi, on this dataset for research purposes.
We split the training data of 13739 cells (9211+4528) into
four folds for cross validation such that each fold contains ap-
proximately equal proportion of images of both the classes
across folds. Also, the folds are prepared at the subject level,
i.e., all cells belonging to the same subject are placed in the
same fold. In addition, we used test data that is not a part of
any fold above and is collected besides the ≈14K cells men-
tioned above, collected from different subjects. Our test data
consisted of 312 cancer cells from 2 cancer subjects and 324
normal cells from 2 normal subjects.
Since WBCs were of varied sizes (roughly 250-300 in
each dimension), we positioned each cell in the middle of
a blank image of size 350x350 with centroid of cell at the
centre. We refrained from downsizing the images to avoid
any loss of information. During training, we applied aug-
mentations such as rotation, horizontal and vertical flip ran-
domly. We also experimented with augmentations such as
shear, Gaussian blur, random crop, and perspective transform.
Out of these, first two worked best on our dataset and hence,
were finally chosen. We have used shear augmentation within
a range of [-20, 20] and Gaussian blur augmentation within a
range of [0.0, 0.75]. These augmentation significantly helped
in improving overall training and hence, the accuracy.
4. LEUKONET ARCHITECTURE
Since limited dataset is available, we trained a small network
from scratch instead of working with deep architectures such
as Resnet [10] or DenseNet [11] to prevent overfitting. We
trained a network with a strided convolutional layer at the
front end followed by 5 convolutional layers with batch-norm,
maxpool and Relu as shown in Fig 1. As proposed by BCNN
[12], bi-linear pooling was used at the end of the network
where the output of the last convolutional layer were flat-
tened along the spatial dimension and the outer product with
its transpose is passed through a linear layer for final classifi-
cation. We refer to this network as the Basic Network.
As proposed in [3], the images were trained in the Opti-
cal Density (OD) space rather than RGB space and used the
Stain Deconvolution Layer (SD Layer) [3] appended at the
beginning of our Basic Network. This combination is further
mentioned as Stage-1.
To emulate the working of flow cytometry, we used Dis-
crete Cosine Transform (DCT) as we believe that there may
be useful features in the frequency domain that can be cap-
tured by DCT. Two-dimensional DCT was applied on the
output of the SD Layer with energy threshold of 95% re-
ducing the values below the threshold to 1. We further
log-normalized the output using log10, while maintaining
the sign of the DCT coefficients. This along with the Basic
Network is referred to as Stage-2.
Since DCT is a non-linear combination of the pixel val-
ues, we believe that the information after the SD layer will be
different than that in the DCT. As an experiment, the three
channels of DCT features after Stage-2 were concatenated
with the three channel features after Stage-1 of the SD Layer.
The concatenated six channel features were fed as input to the
Basic Network, which we refer as Stage-2C.
Experiments showed that different cells were detected er-
roneously from Stage-1 and Stage-2. Hence, to incorporate
the knowledge of both these stages, we extracted features
from both and trained a single Fully Connected (FC) Layer.
This combination ais referred as Stage-3. Further, we experi-
mented with combining Stage-1 and Stage-2C, which we re-
fer to as Stage-3C.
5. EXPERIMENTS
This work is build upon the work in [3]. At first, the SD
Layer of [3] was combined with the VGG-11 network [13].
We observed overfitting of the model showing an increase
in the validation loss during training. We hypothesized that
this happened due to a large number of parameters in the net-
work. Furthermore, the network used global average pooling
in the last convolutional layer to reduce features. However,
this could result in a loss of fine grained information.
To counter the issue of large number of parameters, we
used the basic network shown in Fig.1. This helped us re-
duce the number of trainable features considerably. Also, to
capture the fine grained information, we introduced a binary
pooling layer presented in [12]. We refer to this as ‘Stage-1
w/o aug’ experiment, since we did not introduced any aug-
mentations in the training data yet. This resulted in an in-
crease of 2% in accuracy on the 3rd validation fold (Table-1),
thus validating our hypothesis. However, we observed that al-
though the network performed really well on the cancer class,
the network performed poorly on the normal class. As a re-
sult, a lot of fluctuations in the validation loss was also ob-
served. Results of ‘Stage-1 w/o aug’ on all four validation
sets and the test set are tabulated in Table 2.
Our dataset is skewed in class ratio with the ratio of can-
cer WBCs:Normal WBCs of about 2:1. We believe this to
be the main reason behind the low performance on the Nor-
mal class and the observed fluctuations in the validation loss.
To resolve this, we introduced augmentations in the data that,
in our opinion, simulate conditions of real experiment data
preparation. It was observed that affine augmentation like
shear applied in a range of [-20, 20] works best for our dataset.
This is possibly because cells do get sheared upto some ex-
tent, while the microscopic slides are prepared. Also, there
can be variations in the sharpness of the image because man-
ual focusing of microscope lens was carried out during image
capture. Thus, we used Gaussian blur in the images to induce
the effect. We used the augmented version of Stage-1 model
for this experiment, referred as, ‘Stage1 w/ aug’ throughout
Table 1: Experimental results on Val-3.
F1,N : F1 score on Normal class, F1,C : F1 score on Cancer class.
Model Names Accuracy F1,N F1,C
OD w/ VGG 11 87.07 82.76 89.66
Stage-1 w/o aug 88.92 84.56 91.36
Stage-1 w/ aug 90.22 85.78 92.55
Stage-1 PRelu w/ aug 86.58 81.75 89.39
Stage-1 PTelu w/ aug 88.17 84.09 90.59
Stage-1 w/ Normal aug 89.18 85.01 91.54
Stage-2C w/o aug 87.56 82.39 90.38
Stage-2C PRelu w/o aug 84.28 78.79 87.51
Stage-2C PTelu w/o aug 86.39 81.32 89.29
Stage-3C w/ Normal aug 89.70 85.84 91.95
Stage-3 w/ Normal aug 87.20 82.20 90.01
Note: ReLU activation function is the default if not mentioned with
the model.
this paper.
Since the number of normal WBCs were less, we also
applied the above mentioned augmentations to only Normal
class and then randomly sampled the images choosing the
number of images equal to those of Cancer class. We call
this experiment as ‘Stage-1 w/ Normal aug’. This helped in
further reduction of the fluctuations, indicating better train-
ing. Although fluctuations on the validation set reduced to
some extent, they were still observed.
Furthermore, to find the reason behind the fluctuations
on the validation set, we analyzed the mistakes made by the
‘Stage1 w/ aug’ model. By analyzing the results carefully,
we noted that our model was failing at the subject-level data,
i.e., either most of the cells of a subject were recognized cor-
rectly or were mis-classified. This shows that there is subject
variability in the data and hence, needed to be addressed care-
fully. On the contrary the standard lab test of Flow Cytometry
provides consistent results.
To emulate the Flow Cytometry test that works on the
principle of flow cytometry, we took the Discrete Cosine
Transform (DCT) on the OD space values of the images
and trained the CNN model on the DCT coefficient im-
ages. We call this experiment, ‘Stage-2 w/o aug’ since it
combines Stage-1 architecture with DCT enhancement. Al-
though we observed a decline in the accuracy compared to
‘Stage-1 w/o aug’ (Table-2), some of the hard examples not
classified correctly by ‘Stage-1 w/o aug’ were now being cor-
rectly classified by the ‘Stage-2 w/o aug’ model. Moreover,
the fluctuations observed earlier were reduced considerably.
Since DCT is a non-linear combination, we believe that the
data before and after DCT operation may carry different in-
formation. Thus, the features learned (3 image planes) on
DCT-appended CNN were concatenated with the features
learned by the CNN on the direct OD space (3 image planes).
The concatenated six channel features were used as input to
our ‘Stage-2C w/o aug’ model and compared to ‘Stage-2 w/o
aug’ model. This shows an increase in accuracy (Table-2)
Table 2: Experimental results on all four folds of validation and the test set.
F1,N : F1 score on the Normal class, F1,C : F1 score on the Cancer class.
Model name Val0 Val1 Val2 Val3 Test set
Acc F1,N F1,C Acc F1,N F1,C Acc F1,N F1,C Acc F1,N F1,C Acc F1,N F1,C
Stage-1 w/o aug 93.00 88.57 94.95 93.03 84.09 93.03 92.63 87.06 94.84 88.92 84.56 91.36 88.08 87.94 88.2
Stage-1 w/ aug 93.93 90.58 95.52 91.71 86.41 94.03 93.3 88.14 95.33 90.22 85.78 92.55 88.54 88.88 88.17
Stage-2 w/o aug 92.37 87.62 94.49 88.97 82.13 92.02 88.24 79.87 91.69 85.71 79.19 89.11 81.11 80.51 81.68
Stage-2C w/o aug 93.28 89.58 95.04 91.57 86.97 93.77 88.69 80.63 91.58 87.56 82.39 90.38 83.74 84.06 83.41
Stage-3 w/o aug 94.95 91.95 96.32 88.94 82.49 91.92 92.43 87.21 94.62 86.26 79.81 89.58 87.77 88.08 87.44
Stage-3 w/ aug 94.39 91.38 95.84 90.28 84.45 92.93 94.34 90.47 95.98 87.00 81.50 89.98 89.47 89.88 89.03
Stage-3C w/o aug 94.22 91.02 95.72 91.57 87.24 93.70 91.89 86.18 94.27 88.37 83.52 91.01 89.62 89.89 89.34
Stage-3C w/ aug 94.05 90.99 95.55 91.51 87.19 93.65 93.98 89.79 95.73 88.82 84.10 91.38 89.62 90.24 88.92
with reduction in fluctuations.
We also hypothesized that the unstable training could also
be a result of incorrect activation function. Therefore, to val-
idate this hypothesis, we ran ‘Stage-1 w/aug’ with P-TELU
activation as proposed by Gupta et al. [14] and PReLU acti-
vation function as proposed by He et al. [15]. Although this
increased the parameters marginally, this setup could help us
learn more significant features. In Table 1, we report the re-
sults by using these two activation functions on previous best
models, namely, ‘Stage-1 w/aug’ and ‘Stage-2C w/o aug’.
From the results of Table 1, it can be concluded that for our
problem, ReLU performed best compared to PReLU and P-
TELU.
We further analyzed the results of ‘Stage-2C w/o aug’
model and ‘Stage-1 w/ aug’ on validation set-3. Interestingly,
we observed that the sets of samples on which both the mod-
els were failing, were almost mutually exclusive. Thus, we
combined the two aforesaid models and developed a new hy-
brid model. We call this hybrid model, ‘Stage-3C w/o aug’,
in which we concatenate features from both the networks and
then train a single fully connected (FC) layer. This exper-
iment relied on our hypothesis that, if combined, these two
models would collectively perform better as compared to the
individual models. To further validate our hypothesis and ob-
tain thorough results, we replicated this configuration for the
other possible hybrid of set (‘Stage-2 w/o aug’, ‘Stage-C w/o
aug’) and set (‘Stage-1 w/o aug’, ‘Stage-1 w/aug’). Models
resulting from the hybrid of ‘Stage-1 w/o aug’ with ‘Stage-
2 w/o aug’ and ‘Stage-1 w/o aug’ with ‘Stage-2C w/o aug’
are denoted as ‘Stage-3 w/o aug’ and ‘Stage-3C w/o aug’,
respectively. The ‘w/o’ tag in the hybrid experiment rep-
resents the training configuration of corresponding Stage-1
model. Since we did not achieve good results with ‘Stage-
2C w/ aug’ experiment, we did not proceed with augmenta-
tion on Stage-2. Similarly, hybrids obtained from ‘Stage-1 w/
aug’ with ‘Stage-2 w/o aug’ and ‘Stage-1 w/ aug’ with ‘Stage-
2C w/o aug’ are denoted as ‘Stage-3 w/ aug’ and ‘Stage-3C
w/ aug’ respectively. We report the results of all the men-
tioned hybrids in Table 2. Finally, from Table 2, we observe
that ‘Stage-3C w/ aug’ configuration performs best on our
test set. Furthermore, we experimented with only Normal cell
augmentation for some of our hybrid models, namely ‘Stage 3
w/ Normal aug’ and ‘Stage-3C w/ Normal aug’. Since results
of these hybrids on validation set 3, as referred from Table 1,
were not better than the aforementioned hybrids, we did not
continue with further experimentation on these hybrids.
Each training experiment took approx. 7-10 hours on an
NVIDIA GeForce GTX 1080 Ti GPU, depending upon the
amount of augmentation and depth of the network architec-
ture. We terminated the training process when the accuracy
on the validation set was saturated. Models resulting from
best validation set accuracy were used on the test set.
6. CONCLUSION
In this work, we present a novel CNN architecture, namely,
Leukonet for the classification of cancer cells from nor-
mal cells in white blood cancer. We employed a hybrid
architecture that utilizes the knowledge of two differently
trained models. This improves the classification accuracy.
To achieve this, we fuse the features of CNN model trained
on the DCT of the OD space images with the features of
CNN model trained on the OD space. Model were trained
with and without data augmentation separately and tested
exhaustively. Augmentations of shear and blur present in the
real data guided us to choose these augmentation techniques.
Finally, the best of the models were used to train the hybrid
architecture ensuring that individually learned representa-
tions compliment each other. In the future work, we will try
to improve our results by generating more training images
using Generative adverserial network (GAN) that can provide
better learning and help in overcoming the problem of small
medical imaging data.
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